1 / 5

Point of Care Diagnostics Market Major Drivers, Opportunities and Current Market Trends

The global point of care diagnostics market is US$ 26.60 Bn in 2018 and is predicted to grow at a CAGR of 11.8% during the forecast period 2019 u2013 2027, to reach US$ 70.89 Bn by 2027.

anureddy3
Download Presentation

Point of Care Diagnostics Market Major Drivers, Opportunities and Current Market Trends

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Point of Care Diagnostics Market Publication Month: Aug 2019 | Report Code: TIPRE00006394 | No. of Pages: 202 | Category: Medical Device | Status: Published Point of Care Diagnostics Market to 2027 - Global Analysis and Forecasts By Product (Glucose Monitoring Products, Infectious Disease Testing Products, Cardiometabolic Testing Products, Pregnancy and Fertility Testing Products, Coagulation Testing Products, Tumor/Cancer Marker Testing Products, Cholesterol Testing Products, Urinalysis Testing Products, Hematology Testing Products, Other POC Products), by Prescription Mode (Prescription-Based Testing, OTC Testing), End User (Professional Diagnostic Centers, Home Care, Research Laboratories, Others) and Geography E-Mail : sales@theinsightpartners.com

  2. Point of Care Diagnostics Market Publication Month: Aug 2019 | Report Code: TIPRE00006394 | No. of Pages: 202 | Category: Medical Device | Status: Published Introduction: The global point of care diagnostics market is US$ 26.60 Bn in 2018 and is predicted to grow at a CAGR of 11.8% during the forecast period 2019 – 2027, to reach US$ 70.89 Bn by 2027. The growth of the POC market is mainly attributed to the introduction of new devices to perform molecular testing... Many new devices have been launched in recent years. For instance, in June 2019, Abbott launched first-ever rapid POC HbA1c test to aid in the diagnosis of diabetes; this test provides results in 3 minutes, enabling clinicians to develop informed, individualized care plans during patient consultation. Such advancements in new launched devices will propel the overall POC market growth during the forecast period. E-Mail : sales@theinsightpartners.com

  3. Point of Care Diagnostics Market Publication Month: Aug 2019 | Report Code: TIPRE00006394 | No. of Pages: 202 | Category: Medical Device | Status: Published The global point of care diagnostics market by product was led by glucose monitoring products segment. In 2018, the glucose monitoring products segment held a largest market share of the point of care diagnostics market. This segment is also expected to dominate the market in 2027 owing to the increasing diabetic patients. However, infectious disease testing product market is expected to grow at significant rate in the forecast period. Moreover, Infectious disease rapid test kits are widely available for a wide variety of prophlogistic pathogen targets, including bacterial, viral, fungal, protozoan, and other disease agents. E-Mail : sales@theinsightpartners.com

  4. Point of Care Diagnostics Market Publication Month: Aug 2019 | Report Code: TIPRE00006394 | No. of Pages: 202 | Category: Medical Device | Status: Published There have been limited developments made in the point of care diagnostics market during recent years. However, growth strategies such as approvals, collaborations, and partnerships have been witnessed in the market of point of care diagnostics. For instance, in February 2019, HemoCue AB, a subsidiary of Danaher, received US FDA 510(k) approval of the latest point-of-care hemoglobin test, the HemoCueHb 801 System. Also, during January 2018, PTS Diagnostics, announced that they are releasing PTS Connect ProLink, a cloud-based biometric data collection and transfer software platform that helps retail partners’ pharmacies and clinics provide valuable health screening services to their customers. Company Profiles F. Hoffmann-La Roche Ltd. Danaher Corporation Bio Rad Laboratories Inc. Abbott bioMérieux SA Johnson & Johnson Services, Inc. Nova Biomedical Siemens AG BD PTS Diagnostics E-Mail : sales@theinsightpartners.com

  5. Point of Care Diagnostics Market Publication Month: Aug 2019 | Report Code: TIPRE00006394 | No. of Pages: 202 | Category: Medical Device | Status: Published According to HIV and AIDS organization (AVERT), in 2018, 1.1 million US residents were infected with HIV, whereas APAC registered 5.2 million HIV-infected population. As per European Centre for Disease Prevention and Control, ~2 million people in Europe were infected with HIV in 2018. Such increase in the incidence of infectious diseases is expected to create a demand for point of care test kits across the world. Get a PDF Sample copy of Point of Care Diagnostics Market:- https://www.theinsightpartners.com/sample/TIPRE00006394/ E-Mail : sales@theinsightpartners.com

More Related